Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Lead Finder by BioMolTech Corp. is specialized software for computer-aided drug discovery. Its core uses include virtual screening of candidate drug molecules, ligand docking, 3D structure prediction for protein-ligand complexes, and estimation of binding free energy. Its target users are not general developers, but researchers in computational chemistry, medicinal chemistry, pharmacology and toxicology, biochemistry, and enzymology.
For virtual screening, Lead Finder can dock each ligand in a compound library to a target protein and rank them by predicted binding activity using VS-score. The text states that screening mode is, on average, 2-4 times faster than the default docking mode, with a typical speed of around 5,000 compounds per processor/core per day. For molecular docking, it supports flexible ligands against a static protein structure, can handle both non-covalent and covalent binding complexes, and offers both docking and screening modes. Binding energy estimation uses dG-score, which can be calculated during docking or separately for existing protein-ligand structures. Protein preprocessing capabilities include adding hydrogens, predicting ionization states at a given pH, optimizing polar hydrogens, optimizing His/Asn/Gln side-chain orientations, and handling missing side chains.
The FAQ explicitly states that ligand input formats include mol, mol2, and sdf, while protein structures support mol2, pdb, and gro. The website also provides several downloadable sample tasks, and its scientific documentation cites benchmark comparisons with similar software such as FlexX, Glide, Gold, LigandFit, MolDock, and Surflex. The company announced a strategic partnership with Cresset in 2016.
The text indicates that the product follows a commercial licensing route. The website provides pages for Licensing Policy, Software Evaluation, and Request Quote, but does not publicly disclose specific pricing, trial duration, payment methods, or licensing model details. For buyers, costs need to be confirmed via email or the quote request process.
Its strengths are a complete functional workflow covering protein preparation, screening, docking, and energy estimation, along with relatively extensive benchmark documentation and FAQ material. Its weaknesses are that pricing, API/SDK availability, open-source status, and self-hosted deployment options are all unclear; the website’s news information is also relatively dated, so current maintenance activity should be verified separately. It is better suited to pharmaceutical companies, CROs, university labs, and R&D teams with computational chemistry expertise, and is not ideal for users looking for a modern cloud developer platform or a general-purpose SDK.
The collected text does not provide information on access from mainland China, payment, or local support, so this remains unknown. If the official website cannot be accessed reliably or cross-border procurement is difficult, alternatives such as AutoDock/Vina, Schrödinger Glide, GOLD, and MOE may also be evaluated.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on biomoltech.com official site.
biomoltech.com is an Unknown Dev Tools provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach biomoltech.com directly.